NCT00582816View on ClinicalTrials.gov

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
LeukemiaSolid Tumors
Interventions
DEVICE

Clinimacs Cell Separation System

Depletion of T-cells

DRUG

conditioning chemotherapy

Methylprednisolone, Equine ATG, Cyclosporine, Fludarabine, Melphalan, Thiotepa and Rituximab.

OTHER

DLI

NK Cell selected DLI

Trial Locations (1)

53972

Kenneth DeSantes., MD, Madison

Sponsors

Collaborators (1)

Miltenyi Biomedicine GmbH
All Listed Sponsors
collaborator

Miltenyi Biomedicine GmbH

INDUSTRY

lead

University of Wisconsin, Madison

OTHER